Pietro Invernizzi

Research interests

Publications

• Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

  New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2306185

• An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

  Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.04.055

• Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆

  Journal of Hepatology · 2020 · https://doi.org/10.1016/j.jhep.2020.04.003

• Cholangiocarcinoma 2020: the next horizon in mechanisms and management

  Nature Reviews Gastroenterology & Hepatology · 2020 · https://doi.org/10.1038/s41575-020-0310-z

• Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development

  Journal of Hepatology · 2019 · https://doi.org/10.1016/j.jhep.2019.08.005

• EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

  Journal of Hepatology · 2017 · https://doi.org/10.1016/j.jhep.2017.03.022

• Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

  Gastroenterology · 2017 · https://doi.org/10.1053/j.gastro.2017.02.038

• Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)

  Nature Reviews Gastroenterology & Hepatology · 2016 · https://doi.org/10.1038/nrgastro.2016.51

• Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

  Nature Genetics · 2016 · https://doi.org/10.1038/ng.3745

• A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

  New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1509840

• Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

  Gastroenterology · 2015 · https://doi.org/10.1053/j.gastro.2015.07.061

• Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study

  Gastroenterology · 2014 · https://doi.org/10.1053/j.gastro.2014.08.029

• Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

  Nature Genetics · 2013 · https://doi.org/10.1038/ng.2616

Current projects

No projects listed.